The pathogenesis of oral lichen planus

Critical Reviews in Oral Biology and Medicine

Volumn 13, Issue 4, 2002, Pages 350-365

  Sugerman, P B ^a   Savage, N W ^b   Walsh, L J ^b   Zhao, Z Z ^b   Zhou, X J ^b   Khan, A ^b   Seymour, G J ^b   Bigby, M ^c  

^a ASTRAZENECA   (United Kingdom)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Hypothesis; Oral lichen planus; Pathogenesis

Indexed keywords

ALPHA CHEMOKINE; CD40 ANTIGEN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR10; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR9; CHYMASE; FAS ANTIGEN; G PROTEIN COUPLED RECEPTOR; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GELATINASE A; GELATINASE B; HEAT SHOCK PROTEIN; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN 2; INTERLEUKIN 8; MELANOSTATIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; STROMELYSIN; TRANSFORMING GROWTH FACTOR BETA1; TRYPTASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; APOPTOSIS; BASEMENT MEMBRANE; CARCINOGENESIS; CLINICAL FEATURE; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DISEASE PREDISPOSITION; ENZYME ACTIVATION; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; IMMUNE DEFICIENCY; KERATINOCYTE; LAMINA PROPRIA; LANGERHANS CELL; LICHEN PLANUS; LYMPHOCYTE MIGRATION; MAST CELL DEGRANULATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

EID: 0036929027     PISSN: 10454411     EISSN: None     Source Type: Journal    
DOI: 10.1177/154411130201300405     Document Type: Review

References (204)

1. Aggarwal BB, Samanta A, Feldmann M (2001). TNFα. In: Cytokine Reference. A Compendium of Cytokines and Other Mediators of Host Defense. Oppenheim JJ, Feldmann M, Durum SK, Hirano T, Vilcek J, Nicola NA, editors. San Diego: Academic Press, pp. 413-434.
2. Akhurst RJ, Fee F, Balmain A (1988). Localized production of TGF-beta mRNA in tumour promoter-stimulated mouse epidermis. Nature 331:363-365.
3. Albanesi C, Cavani A, Girolomoni G (1998). Interferon-gamma-stimulated human keratinocytes express the genes necessary for the production of peptide-loaded MHC class II H molecules. J Invest Dermatol 110:138-142.
4. Albert ML, Pearce SF, Francisco LM, Sauter B, Roy P, Silverstein RL, et al. (1998a). Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med 188:1359-1368.
5. Albert ML, Sauter B, Bhardwaj N (1998b). Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392:86-89.
6. Allen CM, Camisa C (2000). Paraneoplastic pemphigus: A review of the literature. Oral Dis 6:208-214.
7. Axéll T, Rundqvist L (1987). Oral lichen planus - A demographic study. Community Dent Oral Epidemiol 15:52-56.
8. Balasa B, Krahl T, Patstone G, Lee J, Tisch R, McDevitt HO, et al. (1997). CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice. J Immunol 159:4620-4627.
9. Balashov KE, Smith DR, Khoury SJ, Hafler DA, Weiner HL (1997). Increased interleukin 12 production in progressive multiple sclerosis: Induction by activated CD4+ T cells via CD40 ligand. Proc Natl Acad Sci USA 94:599-603.
10. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC (1995). A role for CD95 ligand in preventing graft rejection. Nature 377:630-632.
11. Bensaude O, Morange M (1983). Spontaneous high expression of heat-shock proteins in mouse embryonal carcinoma cells and ectoderm from day 8 mouse embryo. EMBO J 2:173-177.
12. Bernhagen J, Bacher M, Calandra T, Metz CN, Doty SB, Donnelly T, et al. (1996). An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction. J Exp Med 183:277-282.
13. Bickel M, Nothen SM, Freiburghaus K, Shire D (1996). Chemokine expression in human oral keratinocyte cell lines and keratinized mucosa. J Dent Res 75:1827-1834.
14. Billiau A, Vanderbroeck K (2001). IFN-γ. In: Cytokine Reference. A Compendium of Cytokines and Other Mediators of Host Defense. Oppenheim JJ, Feldmann M, Durum SK, Hirano T, Vilcek J, Nicola NA, editors. San Diego: Academic Press, pp. 641-688.
15. Birchall MA, Winterford CM, Allan DJ, Harmon BV (1995). Apoptosis in normal epithelium, premalignant and malignant lesions of the oropharynx and oral cavity: A preliminary study. Eur J Cancer B Oral Oncol 31 (B):380-383.
16. Bischoff SC, Krieger M, Brunner T, Rot A, von Tscharner V, Baggiolini M, et al. (1993). RANTES and related chemokines activate human granulocytes through different G protein-coupled receptors. Eur J Immunol 23:761-767.
17. Black MM, Wilson-Jones E (1972). The role of the epidermis in the histopathogenesis of lichen planus. Histochemical correlations. Arch Dermatol 105:81-86.
18. Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, et al. (1997). A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385:729-733.
19. Blazar BR, Taylor PA, Noelle RJ, Vallera DA (1998). CD4(+) T cells tolerized ex vivo to host alloantigen by anti-CD40 ligand (CD40L:CD154) antibody lose their graft-versus-host disease lethality capacity but retain nominal antigen responses. J Clin Invest 102:473-482.
20. Blobe GC, Liu X, Fang SJ, How T, Lodish HF (2001). A novel mechanism for regulating transforming growth factor beta (TGF-beta) signaling. Functional modulation of type III TGF-beta receptor expression through interaction with the PDZ domain protein, GIPC. J Biol Chem 276:39608-39617.
21. Bloor BK, Malik FK, Odell EW, Morgan PR (1999). Quantitative assessment of apoptosis in oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88:187-195.
22. Bolewska J, Hansen HJ, Holmstrup P, Pindborg JJ, Stangerup M (1990). Oral mucosal lesions related to silver amalgam restorations. Oral Surg Oral Med Oral Pathol 70:55-58.
23. Boon L, Brok HP, Bauer J. Ortiz-Buijsse A, Schellekens MM, Ramdien-Murli S, et al. (2001). Prevention of experimental autoimmune encephalomyelitis in the common marmoset (Callithrix jacchus) using a chimeric antagonist monoclonal antibody against human CD40 is associated with altered B cell responses. J Immunol 167:2942-2949.
24. Bos JD, Zonneveld I, Das PK, Kreig SR, van der Loos CM, Kapsenberg ML (1987). The skin immune system (SIS): Distribution and immunophenotype of lymphocyte subpopulations in normal human skin. J Invest Dermatol 88:569-573.
25. Bowen GM, Peters NT, Fivenson DP, Su LD, Nousari HC, Anhalt GJ, et al. (2000). Lichenoid dermatitis in paraneoplastic pemphigus: a pathogenic trigger of epitope spreading? Arch Dermatol 136:652-656.
26. Bowers KE, Sexton J, Sugerman PB (2000). Commentary. Clin Dermatol 18:497-498.
27. Bramanti TE, Dekker NP, Lozada-Nur F, Sauk JJ, Regezi JA (1995). Heat shock (stress) proteins and gamma delta T lymphocytes in oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 80:698-704.
28. Bridoux F, Badou A, Saoudi A, Bernard I, Druet E, Pasquier R, et al. (1997). Transforming growth factor beta (TGF-beta)-dependent inhibition of T helper cell 2 (Th2)-induced autoimmunity by self-major histocompatibility complex (MHC) class H-specific, regulatory CD4(+) T cell lines. J Exp Med 185:1769-1775.
29. Brown GR, Lindberg G, Meddings J, Silva M, Beutler B, Thiele D (1999). Tumor necrosis factor inhibitor ameliorates murine intestinal graft-versus-host disease. Gastroenterology 116:593-601.
30. Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, Alber G (1996). Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 184:747-752.
31. Chainani-Wu N, Silverman S Jr, Lozada-Nur F, Mayer P, Watson JJ (2001). Oral lichen planus: Patient profile, disease progression and treatment responses. J Am Dent Assoc 132:901-909.
32. Chaiyarit P, Kafrawy AH, Miles DA, Zunt SL, Van Dis ML, Gregory RL (1999). Oral lichen planus: An immunohistochemical study of heat shock proteins (HSPs) and cytokeratins (CKs) and a unifying hypothesis of pathogenesis. J Oral Pathol Med 28:210-215.
33. Chen LZ, Hochwald GM, Huang C, Dakin G, Tao H, Cheng C, et al. (1998). Gene therapy in allergic encephalomyelitis using myelin basic protein-specific T cells engineered to express latent transforming growth factor-beta1. Proc Natl Acad Sci USA 95:12516-12521.
34. Chesney J, Metz C, Bacher M, Peng T, Meinhardt A, Bucala R (1999). An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma. Mol Med 5:181-191.
35. Chu J-L, Drappa J, Parnassa A, Elkon KB (1993). The defect in Fas mRNA expression in MRL/lpr mice is associated with insertion of the retrotransposon, ETn. J Exp Med 178:723-730.
36. Ciocca DR, Clark GM, Tandon AK, Fuqua SA, Welch WJ, McGuire WL (1993). Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: Prognostic implications. J Natl Cancer Inst 85:570-574.
37. Claman HN (1985). Mast cell depletion in murine chronic graft-versus-host disease. J Invest Dermatol 84:246-248.
38. Constant SL, Bottomly K (1997). Induction of Th1 and Th2 CD4+ T cell responses: The alternative approaches. Annu Rev Immunol 15:297-322.
39. Costa GL, Sandora MR, Nakajima A, Nguyen EV, Taylor-Edwards C, Slavin AJ, et al. (2001). Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit. J Immunol 167:2379-2387.
40. Coussens LM, Tinkle CL, Hanahan D, Werb Z (2000). MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103:481-490.
41. Cui W, Fowlis DJ, Bryson S, Duffie E, Ireland H, Balmain A, et al. (1996). TGFβ1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 86:531-542.
42. Dang H, Geiser AG, Letterio JJ, Nakabayashi T, Kong L, Fernandes G, et al. (1995). SLE-like autoantibodies and Sjögren's syndrome-like lymphoproliferation in TGF-beta knockout mice. J Immunol 155:3205-3212.
43. Debray-Sachs M, Carnaud C, Boitard C, Cohen H, Gresser I, Bedossa P, et al. (1991). Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma. J Autoimmun 4:237-248.
44. Dekker NP, Lozada-Nur F, Lagenaur LA, MacPhail LA, Bloom CY, Regezi JA (1997). Apoptosis-associated markers in oral lichen planus. J Oral Pathol Med 26:170-175.
45. Delaney CL, Russell JW, Cheng HL, Feldman EL (2001). Insulin-like growth factor-I and over-expression of Bcl-xL prevent glucose-mediated apoptosis in Schwann cells. J Neuropathol Exp Neurol 60:147-160.
46. Donath MY, Gross DJ, Cerasi E, Kaiser N (1999). Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes 48:738-744.
47. Durie FH, Fava RA, Foy TM, Aruffo A, Ledbetter JA, Noelle RJ (1993). Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 261:1328-1330.
48. Durie FH, Aruffo A, Ledbetter J, Crassi KM, Green WR, Fast LD, et al. (1994). Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease. J Clin Invest 94:1333-1338.
49. Dyntar D, Eppenberger-Eberhardt M, Maedler K, Pruschy M, Eppenberger HM, Spinas GA, et al. (2001). Glucose and palmitic acid induce degeneration of myofibrils and modulate apoptosis in rat adult cardiomyocytes. Diabetes 50:2105-2113.
50. Eisen D (1993). The therapy of oral lichen planus. Crit Rev Oral Biol Med 4:141-158.
51. Eisen D (1999). The evaluation of cutaneous, genital, scalp, nail, esophageal, and ocular involvement in patients with oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88:431-436.
52. Eisenberg E (2000). Oral lichen planus: A benign lesion. J Oral Maxillofac Surg 58:1278-1285.
53. Elliott MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Katsikis P, et al. (1993). Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum 36:1681-1690.
54. Elliott MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen JS, et al. (1994). Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet 344:1105-1110.
55. Esche C, Shurin MR, Lotze MT (2001). IL-12. In: Cytokine Reference. A Compendium of Cytokines and Other Mediators of Host Defense. Oppenheim JJ, Feldmann M, Durum SK, Hirano T, Vilcek J, Nicola NA, editors. San Diego: Academic Press, pp. 187-201.
56. Fang KC, Raymond WW, Blount JL, Caughey GH (1997). Dog mast cell alpha-chymase activates progelatinase B by cleaving the Phe88-Gln89 and Phe91-Glu92 bonds of the catalytic domain. J Biol Chem 272:25628-25635.
57. Farthing PM, Cruchley AT (1989). Expression of MHC class II antigens (HLA DR, DP and DQ) by keratinocytes in oral lichen planus. J Oral Pathol Med 18:305-309.
58. Farthing PM, Matear P, Cruchley AT (1990). The activation of Langerhans cells in oral lichen planus. J Oral Pathol Med 19:81-85.
59. δ2T cells of a GroEL homolog on Daudi Burkitt's lymphoma cells. Science 250:1269-1273.
60. Flanders KC, Roberts AB (2001). TGFβ. In: Cytokine Reference. A Compendium of Cytokines and Other Mediators of Host Defense. Oppenheim JJ, Feldmann M, Durum SK, Hirano T, Vilcek J, Nicola NA, editors. San Diego: Academic Press, pp. 719-746.
61. Fujii H, Ohashi M, Nagura H (1988). Immunohistochemical analysis of oral lichen planus-like eruption in graft-versus-host disease after allogeneic bone marrow transplantation. Am J Clin Pathol 89:177-186.
62. Fukaura H, Kent SC, Pietrusewicz MJ, Khoury SJ, Weiner HL, Hafler DA (1996). Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-betal-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J Clin Invest 98:70-77.
63. Gallucci S, Matzinger P (2001). Danger signals: SOS to the immune system. Curr Opin Immunol 13:114-119.
64. Gammon G, Sercarz E (1989). How some T cells escape tolerance induction. Nature 342:183-185.
65. Gearing AJ, Beckett P, Christodoulou M, Churchill M, Clements J, Davidson AH, et al. (1994). Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature 370:555-557.
66. Gerritse K, Laman JD, Noelle RJ, Aruffo A, Ledbetter JA, Boersma WJ, et al. (1996). CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci USA 93:2499-2504.
67. Gmeinhart B, Hinterberger W, Greinix HT, Rabitsch W, Kimbauer R, Reiter E, et al. (1999). Anaplastic squamous cell carcinoma (SCC) in a patient with chronic cutaneous graft-versus-host disease (GVHD). Bone Marrow Transplant 23:1197-1199.
68. Gorelik L, Flavell RA (2001). Immune-mediated eradication of tumors through the blockade of transforming growth factor-β signaling in T cells. Nature Med 7:1118-1122.
69. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA (1995). Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270:1189-1192.
70. Haapalainen T, Oksala O, Kallioinen M, Oikarinen A, Larjava H, Salo T (1995). Destruction of the epithelial anchoring system in lichen planus. J Invest Dermatol 105:100-103.
71. Hashimoto K (1976). Apoptosis in lichen planus and several other dermatoses. Acta Dermatol Venereol 56:187-210.
72. Hattori K, Hirano T, Ushiyama C, Miyajima H, Yamakawa N, Ikeda S, et al. (1999). A metalloproteinase inhibitor prevents acute graft-versus-host disease in mice after bone marrow transplantation. Bone Marrow Transplant 23:1283-1289.
73. Heyden G, Arwill T, Gisslen H (1974). Histochemical studies on lichen planus. Oral Surg Oral Med Oral Pathol 37:239-248.
74. Herve P, Flesch M, Tiberghien P, Wijdenes J, Racadot E, Bordigoni P, et al. (1992). Phase I-II trial of mononuclear anti-tumor necrosis factor-α antibody for the treatment of refractory severe acute graft-versus-host disease. Blood 79:3362-3368.
75. Ho FM, Liu SH, Liau CS, Huang PJ, Lin-Shiau SY (2000). High glucose-induced apoptosis in human endothelial cells is mediated by sequential activations of c-Jun NH(2)-terminal kinase and caspase-3. Circulation 101:2618-2624.
76. Holmstrup P, Dabelsteen E (1979). Changes in carbohydrate expression of lichen planus affected oral epithelial cell membranes. J Invest Dermatol 73:364-367.
77. Huang F-P, Platt N, Wykes M, Major JR, Powell TJ, Jenkins CD, et al. (2000). A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J Exp Med 191:435-443.
78. Hudson JD, Shaoibi MA, Maestro R, Carnero A, Hannon GJ, Beach DH (1999). A proinflammatory cytokine inhibits p53 tumor suppressor activity. J Exp Med 190:1375-1382.
79. Inaba K, Turley S, Yamaide F, Iyoda T, Mahnke K, Inaba M, et al. (1998). Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J Exp Med 188:2163-2173.
80. Ishii T (1987). Immunohistochemical demonstration of T cell subsets and accessory cells in oral lichen planus. J Oral Pathol 16:356-361.
81. Itai T, Tanaka M, Nagata S (2001). Processing of tumor necrosis factor by the membrane-bound TNF-alpha-converting enzyme, but not its truncated soluble form. Eur J Biochem 268:2074-2082.
82. Johns LD, Sriram S (1993). Experimental allergic encephalomyelitis: Neutralizing antibody to TGF beta 1 enhances the clinical severity of the disease. J Neuroimmunol 47:1-7.
83. Johns LD, Flanders KC, Ranges GE, Sriram S (1991). Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-beta 1. J Immunol 147:1792-1796.
84. Jungell P, Konttinen YT, Malmström M (1989a). Basement membrane changes in oral lichen planus. Proc Finn Dent Soc 85:119-124.
85. Jungell P, Konttinen YT, Nortamo P, Malmström M (1989b). Immunoelectron microscopic study of distribution of T cell subsets in oral lichen planus. Scand J Dent Res 97:361-367.
86. Kane LP, Shapiro VS, Stokoe D, Weiss A (1999). Induction of NF-kappaB by the Akt/PKB kinase. Curr Biol 9:601-604.
87. Kang K, Kubin M, Cooper KD, Lessin SR, Trinchieri G, Rook AH (1996). IL-12 synthesis by human Langerhans cells. J Immunol 156:1402-1407.
88. Kaur I, Voss SD, Gupta RS, Schell K, Fisch P, Sondel PM (1993). Human peripheral gamma delta T cells recognize hsp60 molecules on Daudi Burkitt's lymphoma cells. J Immunol 150:2046-2055.
89. Kelsall BL, Stuber E, Neurath M, Strober W (1996). Interleukin-12 production by dendritic cells. The role of CD40-CD40L interactions in Th1 T-cell responses. Ann New York Acad Sci 795:116-126.
90. Kennedy MK, Picha KS, Fanslow WC, Grabstein KH, Alderson MR, Clifford KN, et al. (1996). CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages. Eur J Immunol 26:370-378.
91. Khan A, Farah CS, Savage NW, Walsh LJ, Harbrow DJ, Sugerman PB (2001). Cytokines in oral lichen planus. J Oral Pathol Med (submitted).
92. Kilpi AM (1987). Activation marker analysis of mononuclear cell infiltrates of oral lichen planus in situ. Scand J Dent Res 95:174-180.
93. Kilpi AM (1988). Characterization of mononuclear cells of inflammatory infiltrates in oral tissues. A histochemical and immunohistochemical study of labial salivary glands in Sjögren's syndrome and of oral lesions in systemic lupus erythematosus and in lichen planus. Proc Finn Dent Soc 84:5-93.
94. Kimura E, Enns RE, Alcaraz JE, Arboleda J, Slamon DJ, Howell SB (1993). Correlation of the survival of ovarian cancer patients with mRNA expression of the 60-kD heat-shock protein HSP-60. J Clin Oncol 11:891-898.
95. Klein LM, Lavker RM, Matis WL, Murphy GF (1989). Degranulation of human mast cells induces an endothelial antigen central to leukocyte adhesion. Proc Natl Acad Sci USA 86:8972-8976.
96. Kristensen M, Chu CQ, Eedy DJ, Feldmann M, Brennan FM, Breathnach SM (1993). Localization of tumour necrosis factor-alpha (TNT-alpha) and its receptors in normal and psoriatic skin: Epidermal cells express the 55-kD but not the 75-kD TNF receptor. Clin Exp Immunol 94:354-362.
97. Kuechle MK (2001). Graft Versus Host Disease. e-Medicine http://emedicine.com/derm/topic478.htm (accessed May 2001).
98. Kuruvilla AP, Shah R, Hochwald GM, Liggitt HD, Palladino MA, Thorbecke GJ (1991). Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice. Proc Natl Acad Sci USA 88:2918-2921.
99. Leonard JP, Waldburger KE, Goldman SJ (1995). Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J Exp Med 181:381-386.
100. Letterio JJ, Roberts AB (1998). Regulation of immune responses by TGF-β. Annu Rev Immunol 16:137-161.
101. Leung BP, McInnes IB, Esfandiari E, Wei XQ, Liew FY (2000). Combined effects of IL-12 and IL-18 on the induction of collagen-induced arthritis. J Immunol 164:6495-6502.
102. Lienerluke B, Germann T, Kroczek RA, Hecker M (2000). CD154 stimulation of interleukin-12 synthesis in human endothelial cells. Eur J Immunol 30:2864-2870.
103. Lind PO (1988). Oral lichenoid reactions related to composite restorations. Acta Odontol Scand 46:63-65.
104. MacDonald KP, Nishioka Y, Lipsky PE, Thomas R (1997). Functional CD40 ligand is expressed by T cells in rheumatoid arthritis. J Clin Invest 100:2404-2414.
105. Malfait AM, Butler DM, Presky DH, Maini RN, Brennan FM, Feldmann M (1998). Blockade of IL-12 during the induction of collagen-induced arthritis (CIA) markedly attenuates the severity of the arthritis. Clin Exp Immunol 111:377-383.
106. Marinkovich MP, Keene DR, Rimberg CS, Burgeson RE (1993). Cellular origin of the dermal-epidermal basement membrane. Dev Dyn 197:255-267.
107. Mason D, Powrie F (1998). Control of immune pathology by regulatory T cells. Curr Opin Immunol 10:649-655.
108. Massagué J (1998). TGF-beta signal transduction. Annu Rev Biochem 67:753-791.
109. Matthews JB, Scully CM, Potts AJ (1984). Oral lichen planus: An immunoperoxidase study using monoclonal antibodies to lymphocyte subsets. Br J Dermatol 111:587-595.
110. Matthys P, Vermeire K, Mitera T, Heremans H, Huang S, Billiau A (1998). Anti-IL-12 antibody prevents the development and progression of collagen-induced arthritis in IFN-gamma receptor-deficient mice. Eur J Immunol 28:2143-2151.
111. Mattsson T, Sundqvist KG, Heimdahl A, Dahllöf G, Ljungman P, Ringdén O (1992). A comparative immunological analysis of the oral mucosa in chronic graft-versus-host disease and oral lichen planus. Arch Oral Biol 37:539-547.
112. McGeehan GM, Becherer JD, Bast RC Jr, Boyer CM, Champion B, Connolly KM, et al. (1994). Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor. Nature 370:558-561.
113. Miller RL, Gould AR, Bernstein ML (1992). Cinnamon-induced stomatitis venenata. Clinical and characteristic histopathologic features. Oral Surg Oral Med Oral Pathol 73:708-716.
114. Miller SD, Vanderlugt CL, Lenschow DJ, Pope JG, Karandikar NJ, Dal Canto MC, et al. (1995). Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity 3:739-745.
115. Miwa K, Hashimoto H, Yatomi T, Nakamura N, Nagata S, Suda T (1999). Therapeutic effect of an anti-Fas ligand mAb on lethal graft-versus-host disease. Int Immunol 11:925-931.
116. Moley KH, Chi MM, Knudson CM, Korsmeyer SJ, Mueckler MM (1998). Hyperglycemia induces apoptosis in pre-implantation embryos through cell death effector pathways. Nature Med 4:1421-1424.
117. Morhenn VB, Wood GS (1988). Gamma interferon-induced expression of class II major histocompatibility complex antigens by human keratinocytes. Effects of conditions of culture. Ann NY Acad Sci 548:321-330.
118. Morita Y, Yamamura M, Nishida K, Harada S, Okamoto H, Inoue H, et al. (1998). Expression of interleukin-12 in synovial tissue from patients with rheumatoid arthritis. Arthritis Rheum 41:306-314.
119. Moss ML, Jin SL, Milla ME, Bickett DM, Burkhart W, Carter HL, et al. (1997). Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 385:733-736.
120. Muller G, Saloga J, Germann T, Bellinghausen I, Mohamadzadeh M, Knop J, et al. (1994). Identification and induction of human keratinocyte-derived IL-12. J Clin Invest 94:1799-1805.
121. Murphy GF, Sueki H, Teuscher C, Whitaker D, Korngold R (1994). Role of mast cells in early epithelial target cell injury in experimental acute graft-versus-host disease. J Invest Dermatol 102:451-461.
122. Naruse K, Nakamura J, Hamada Y, Nakayama M, Chaya S, Komori T, et al. (2000). Aldose reductase inhibition prevents glucose-induced apoptosis in cultured bovine retinal microvascular pericytes. Exp Eye Res 71:309-315.
123. Neppelberg E, Johannessen AC, Jonsson R (2001). Apoptosis in oral lichen planus. Eur J Oral Sci 109:361-364.
124. Newlands GF, Mowat AM, Felstein MV, Miller HR (1990). Role of mucosal mast cells in intestinal graft-versus-host reaction in the mouse. Int Arch Allergy Appl Immunol 93:308-313.
125. Nicoletti F, Zaccone P, Di Marco R, Lunetta M, Magro G, Grasso S, et al. (1997). Prevention of spontaneous autoimmune diabetes in diabetes-prone BB rats by prophylactic treatment with antirat interferon-gamma antibody. Endocrinology 138:281-288.
126. Nicoletti F, Di Marco R, Zaccone P, Magro G, Di Mauro M, Grasso S, et al. (1999). Endogenous interleukin-12 only plays a key pathogenetic role in non-obese diabetic mouse diabetes during the very early stages of the disease. Immunology 97:367-370.
127. Ortiz A, Ziyadeh FN, Neilson EG (1997). Expression of apoptosis-regulatory genes in renal proximal tubular epithelial cells exposed to high ambient glucose and in diabetic kidneys. J Invest Med 45:50-56.
128. Otsubo H, Yokoe H, Miya T, Atsuta F, Miura N, Tanzawa H, et al. (1997). Gingival squamous cell carcinoma in a patient with chronic graft-versus-host disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 84:171-174.
129. Parr MB, Kepple L, Parr EL (1991). Langerhans cells phagocytose vaginal epithelial cells undergoing apoptosis during the murine estrous cycle. Biol Reprod 45:252-260.
130. Pasche B (2001). Role of transforming growth factor beta in cancer. J Cell Physiol 186:153-168.
131. Piguet PF, Grau GE, Allet B, Vassalli P (1987). Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease. J Exp Med 166:1280-1289.
132. Piguet PF, Grau GE, Vesin C, Loetscher H, Gentz R, Lesslauer W (1992). Evolution of collagen arthritis in mice is arrested by treatment with anti-tumour necrosis factor (TNF) antibody or a recombinant soluble TNF receptor. Immunology 77:510-514.
133. Porter SR, Scully C (2000). Adverse drug reactions in the mouth. Clin Dermatol 18:525-532.
134. Prud'homme GJ, Chang Y (1999). Prevention of autoimmune diabetes by intramuscular gene therapy with a nonviral vector encoding an interferon-gamma receptor/IgG1 fusion protein. Gene Ther 6:771-777.
135. Pullan S, Wilson J, Metcalfe A, Edwards GM, Goberdhan N, Tilly J, et al. (1996). Requirement of basement membrane for the suppression of programmed cell death in mammary epithelium. J Cell Sci 109:631-642.
136. Racke MK, Dhib-Jalbut S, Cannella B, Albert PS, Raine CS, McFarlin DE (1991). Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1. J Immunol 146:3012-3017.
137. Racke MK, Cannella B, Albert P, Sporn M, Raine CS, McFarlin DE (1992). Evidence of endogenous regulatory function of transforming growth factor-beta 1 in experimental allergic encephalomyelitis. Int Immunol 4:615-620.
138. Ragaz A, Ackerman AB (1981). Evolution, maturation and regression of lesions of lichen planus. New observations and correlations of clinical and histologic findings. Am J Dermatopathol 3:5-25.
139. Rich AM, Reade PC (1989). A quantitative assessment of Langerhans cells in oral mucosal lichen planus and leukoplakia. Br J Dermatol 120:223-228.
140. Roopenian DC (1992). What are minor histocompatibility loci? A new look at an old question. Immunol Today 13:7-10.
141. Rovere P, Vallinoto C, Bondanza A, Crosti MC, Rescigno M, Ricciardi Castagnoli P, et al. (1998). Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function. J Immunol 161:4467-4471.
142. Sallusto F, Lanzavecchia A, Mackay CR (1998). Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today 19:568-574.
143. Sarkany L, Gaylarde PM (1971). Ultrastructural and light microscopic changes of the epidermo-dermal junction. Trans St John's Hosp Dermatol Soc 57:139-142.
144. Sauter B, Albert ML, Francisco L, Larsson M, Somersan S, Bhardwaj N (2000). Consequences of cell death: Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med 191:423-434.
145. Schubert MM, Sullivan KM (1990). Recognition, incidence, and management of oral graft-versus-host disease. NCI Monogr 9:135-143.
146. Scully C, El-Kom M (1985). Lichen planus: Review and update on pathogenesis. J Oral Pathol 14:431-458.
147. Scully C, Beyli M, Ferreiro MC, Ficarra G, Gill Y, Griffiths M, et al. (1998). Update on oral lichen planus: Etiopathogenesis and management. Crit Rev Oral Biol Med 9:86-122.
148. Sekine C, Yagita H, Miyasaka N, Okumura K (1998). Expression and function of CD40 in rheumatoid arthritis synovium. J Rheumatol 25:1048-1053.
149. Setterfield J, Shirlaw PJ, Lazarova Z, Bryant BM, Bhogal BS, Harman K, et al. (1999). Paraneoplastic cicatricial pemphigoid. Br J Dermatol 141:127-131.
150. Seung E, Iwakoshi N, Woda BA, Markees TG, Mordes JP, Rossini AA, et al. (2000). Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti-CD154 antibody: Absence of graft-versus-host disease, induction of skin allograft tolerance, and prevention of recurrent autoimmunity in islet-allografted NOD/Lt mice. Blood 95:2175-2182.
151. Shimizu M, Higaki M, Kawashima M (1997). The role of granzyme B-expressing CD8-positive T cells in apoptosis of keratinocytes in lichen planus. Arch Dermatol Res 289:527-532.
152. Shimizu T, Abe R, Nakamura H, Ohkawara A, Suzuki M, Nishihira J (1999). High expression of macrophage migration inhibitory factor in human melanoma cells and its role in tumor cell growth and angiogenesis. Biochem Biophys Res Commun 264:751-758.
153. Shlomchik WD, Couzens MS, Tang CB, McNiff J, Robert ME, Liu J, et al. (1999). Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 285:412-415.
154. Shu U, Kiniwa M, Wu CY, Maliszewski C, Vezzio N, Hakimi J, et al. (1995). Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur J Immunol 25:1125-1128.
155. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, et al. (1992). Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359:693-699.
156. Sigidin YA, Loukina GV, Skurkovich B, Skurkovich S (2001). Randomized, double-blind trial of anti-interferon-gamma antibodies in rheumatoid arthritis. Scand J Rheumatol 30:203-207.
157. Silverman S (2000). Oral lichen planus: A potentially premalignant lesion. J Oral Maxillofac Surg 58:1286-1288.
158. Silverman S Jr, Gorsky M, Lozada-Nur F, Giannotti K (1991). A prospective study of findings and management in 214 patients w0ith oral lichen planus. Oral Surg Oral Med Oral Pathol 72:665-670.
159. Simark-Mattsson C, Jontell M, Bergenholtz G, Heyden M, Dahlgren UI (1998). Distribution of interferon-gamma mRNA-positive cells in oral lichen planus lesions. J Oral Pathol Med 27:483-488.
160. Simark-Mattsson C, Bergenholtz G, Jontell M, Eklund C, Seymour GJ, Sugerman PB, et al. (1999). Distribution of interleukin-2, -4, -10, tumour necrosis factor-α and transforming growth factor-β mRNAs in oral lichen planus. Arch Oral Biol 44:499-507.
161. Spandau U, Toksoy A, Goebeler M, Brocker EB, Gillitzer R (1998). MIG is a dominant lymphocyte-attractant chemokine in lichen planus lesions. J Invest Dermatol 111:1003-1009.
162. Spetz A-L, Strominger J, Groh-Spies V (1996). T cell subsets in normal human epidermis. Am J Pathol 149:665-674.
163. Steinman RM, Turley S, Mellman I, Inaba K (2000). The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med 191:411-416.
164. Strober W, Kelsall B, Fuss I, Marth T, Ludviksson B, Ehrhardt R, et al. (1997). Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation. Immunol Today 18:61-64.
165. Stuber E, Buschenfeld A, von Freier A, Arendt T, Folsch UR (1999). Intestinal crypt cell apoptosis in murine acute graft versus host disease is mediated by tumour necrosis factor alpha and not by the FasL-Fas interaction: Effect of pentoxifylline on the development of mucosal atrophy. Gut 45:229-235.
166. Sugerman PB, Savage NW (1999). Current concepts in oral cancer. Aust Dent J 44:147-156.
167. Sugerman PB, Rollason PA, Savage NW, Seymour GJ (1992). Suppressor cell function in oral lichen planus. J Dent Res 71:1916-1919.
168. Sugerman PB, Savage NW, Walsh LJ, Seymour GJ (1993). Disease mechanisms in oral lichen planus. A possible role for autoimmunity. Australas J Dermatol 34:63-69.
169. Sugerman PB, Savage NW, Seymour GJ (1994). Phenotype and suppressor activity of T lymphocyte clones extracted from lesions of oral lichen planus. Br J Dermatol 131:319-324.
170. Sugerman PB, Savage NW, Xu LJ, Walsh LJ, Seymour GJ (1995). Heat shock protein expression in oral lichen planus. J Oral Pathol Med 24:1-8.
171. Sugerman PB, Savage NW, Seymour GJ, Walsh LJ (1996). Is there a role for tumour necrosis factor alpha (TNF-α) in oral lichen planus? J Oral Pathol Med 25:219-224.
172. Sugerman PB, Savage NW, Zhou X, Walsh LJ, Bigby M (2000a). Oral lichen planus. Clin Dermatol 18:533-539.
173. Sugerman PB, Satterwhite K, Bigby M (2000b). Auto-cytotoxic T cell clones in lichen planus. Br J Dermatol 142:449-456.
174. Suss G, Shortman K (1996). A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J Exp Med 183:1789-1796.
175. Takahashi N, Nishihira J, Sato Y, Kondo M, Ogawa H, Ohshima T, et al. (1998). Involvement of macrophage migration inhibitory factor (MIF) in the mechanism of tumor cell growth. Mol Med 4:707-714.
176. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, et al. (1994). Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969-976.
177. Thompson NL, Flanders KC, Smith JM, Ellingsworth LR, Roberts AB, Sporn MB (1989). Expression of transforming growth factor-β1 in specific cells and tissues of adult and neonatal mice. J Cell Biol 108:661-669.
178. Thorbecke GJ, Shah R, Leu CH, Kuruvilla AP, Hardison AM, Palladino MA (1992). Involvement of endogenous tumor necrosis factor alpha and transforming growth factor beta during induction of collagen type II arthritis in mice. Proc Natl Acad Sci USA 89:7375-7379.
179. Trembleau S, Penna G, Bosi E, Mortara A, Gately MK, Adorini L (1995). Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J Exp Med 181:817-821.
180. Trembleau S, Penna G, Gregori S, Gately MK, Adorini L (1997). Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes. Eur J Immunol 27:2330-2339.
181. Ulloa L, Doody J, Massagué J (1999). Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway. Nature 397:710-713.
182. Ullrich SJ, Robinson EA, Law LW, Willingham M, Appella E (1986). A mouse tumor-specific transplantation antigen is a heat shock-related protein. Proc Natl Acad Sci USA 83:3121-3125.
183. van den Brink MR, Moore E, Horndasch KJ, Crawford JM, Hoffman J, Murphy GF, et al. (2000). Fas-deficient lpr mice are more susceptible to graft-versus-host disease. J Immunol 164:469-480.
184. Vincent SD, Fotos PG, Baker KA, Williams TP (1990). Oral lichen planus: The clinical, historical, and therapeutic features of 100 cases. Oral Surg Oral Med Oral Pathol 70:165-171.
185. Walsh LJ, Ishii T, Savage NW, Gemmell E, Seymour GJ (1990a). Immunolhistologic analysis of epithelial cell populations in oral lichen planus. J Oral Pathol Med 19:177-181.
186. Walsh LJ, Savage NW, Ishii T, Seymour GJ (1990b). Immunopathogenesis of oral lichen planus. J Oral Pathol Med 19:389-396.
187. Walsh LJ, Trinchieri G, Waldorf HA, Whitaker D, Murphy GF (1991). Human dermal mast cells contain and release tumor necrosis factor α, which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci USA 88:4220-4224.
188. Walsh LJ, Davis MF, Xu LJ, Savage NW (1995). Relationship between mast cell degranulation and inflammation in the oral cavity. J Oral Pathol Med 24:266-272.
189. Walton LJ, Thornhill MH, Farthing PM (1994). VCAM-1 and ICAM-1 are expressed by Langerhans cells, macrophages and endothelial cells in oral lichen planus. J Oral Pathol Med 23:262-268.
190. Walton LJ, Macey MG, Thornhill MH, Farthing PM (1998). Intraepithelial subpopulations of T lymphocytes and Langerhans cells in oral lichen planus. J Oral Pathol Med 27:116-123.
191. Weedon D (1980). Apoptosis in lichen planus. Clin Exp Dermatol 5:425-430.
192. Williams RO, Feldmann M, Maini RN (1992). Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl Acad Sci USA 9:9784-9788.
193. Windhagen A, Newcombe J, Dangond F, Strand C, Woodroofe MN, Cuzner ML, et al. (1995). Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J Exp Med 182:1985-1996.
194. Yamamoto T, Osaki T (1995). Characteristic cytokines generated by keratinocytes and mononuclear infiltrates in oral lichen planus. J Invest Dermatol 104:784-788.
195. Yamamoto T, Osaki T, Yoneda K, Ueta E (1994). Cytokine production by keratinocytes and mononuclear infiltrates in oral lichen planus. J Oral Pathol Med 23:309-315.
196. Yamamoto T, Nakane T, Osaki T (2000). The mechanism of mononuclear cell infiltration in oral lichen planus: The role of cytokines released from keratinocytes. J Clin Immunol 20:294-305.
197. Yang X, Letterio JJ, Lechleider RJ, Chen L, Hayman R, Gu H, et al. (1999). Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. EMBO J 18:1280-1291.
198. Yiannias JA, el-Azhary RA, Hand JH, Pakzad SY, Rogers RS 3rd (2000). Relevant contact sensitivities in patients with the diagnosis of oral lichen planus. J Am Acad Dermatol 42:177-182.
199. Zhao ZZ, Savage NW, Pujic Z, Walsh LJ (1997). Immunohistochemical localization of mast cells and mast cell-nerve interactions in oral lichen planus. Oral Dis 3:71-76.
200. Zhao ZZ, Sugerman PB, Zhou XJ, Walsh LJ, Savage NW (2001). Mast cell degranulation and the role of T cell RANTES in oral lichen planus. Oral Dis 7:246-251.
201. Zhao ZZ, Sugerman PB, Walsh LJ, Savage NW (2002). Expression of RANTES and CCR1 in oral lichen planus and association with mast cell migration. J Oral Pathol Med 31:158-162.
202. Zhou XJ, Savage NW, Sugerman PB, Walsh LJ, Aldred MJ, Seymour GJ (1996). TCR Vβ gene expression in lesional T lymphocyte cell lines in oral lichen planus. Oral Dis 2:295-298.
203. Zhou XJ, Sugerman PB, Savage NW, Walsh LJ (2001). Matrix metalloproteinases and their inhibitors in oral lichen planus. J Cutan Pathol 28:72-82.
204. Zhou XJ, Sugerman PB, savage NW, Walsh LJ, Seymour GJ (2002). Intra-epithelial CD8+ T cells and basement membrane disruption in oral lichen planus. J Oral Pathol Med 31:23-27.